▲ Pfizer CEO Albert Bulla
Albert Bulla, CEO of US pharmaceutical company Pfizer, said that the drug treatment for COVID-19 developed by the company will also be effective against omicron mutations.
CEO Bulla appeared on CNBC on the 29th local time, referring to Pfizer's oral antiviral drug Paxrovid, saying, "We have a very high level of confidence that our oral treatment will not be affected by this mutant virus. there,” he emphasized.
"I don't think it's going to result in a vaccine that doesn't protect the human body," he said. there,” he added.
"We have said many times that we will have a vaccine in 100 days," he said, adding that work had already begun to develop a new vaccine if needed.
Stefan Bansel, CEO of another vaccine maker, Moderna, also appeared on CNBC on the same day, predicting that "it will be several months before we are ready to mass-produce a vaccine against a specific mutation called Omicron."
Although he believes that the Omicron mutation will be very contagious, Bancel said it would take at least two weeks to determine how much the mutation will affect the effectiveness of existing vaccines.